Press Releases
   Company Newsletter
   Media Coverage
   Special Events
   
     
 
   
 

Current Issues - Newsletter
January 1998

 
 
 

NEWS FLASH

 
 
   
  Gugulipid®: Importance of Proper Standardization
 
 
  Gugulipid®, a registered trademark of Sabinsa Corporation, is the standardized extract of the oleoresin of Commiphora mukul, an Indian medicinal plant. The resin is a mixture of diterpenes, sterols, steroids, esters and higher alcohols. The active ingredients responsible for the well-known hypolipidemic effects of the plant are the guggulsterones, specifically guggulsterone E and guggulsterone Z.

When purchasing guggul products, it is vital that the extract be assessed for purity and appropriate standardization. Sabinsa's product Gugulipid® is purified and standardized to contain a minimum of 2.5% guggulsterones E and Z (the Indian pharmacopeia (IP) limits the maximum level of guggtulsterones to not more than 6.0%).

It is probable that guggul products which claim an active ingredient level in excess of 6.0% may be crude and unpurified extracts. In clinical studies, the administration of crude (unpurified) guggul caused mild side effects such as skin rashes, diarrhea and irregular menstruation. There are no reports of these undesirable effects with the purified and appropriately standardized extract.

 
   
 

New Product: Fenusterols™

 
 
 
Sabinsa Corporation will shortly introduce to the marketplace another new product derived from Fenugreek (Trigonella foenum-graecum). The product, Fenusterols™ is an extract obtained from defatted fenugreek seeds and is standardized to contain a minimum of 50% steroidal saponins. These saponins are also known as furostanol saponins.

General Structure of a Furostanol Saponin
The principal furostanol saponin in Fenugreek is diosgenin. Diosgenin has been proven to have various effects on cholesterol metabolism, specifically in lowering LDL plasma cholesterol levels. Other furostanols in fenugreek include gitogenin, tigogenin, smilagenin, sarsasaponin, etc.

In light of the effect which furostanol saponins exert on appetite stimulation and hormone release, Fenusterols™ may be potentially useful in Sports Nutrition. Fenugreek seeds are traditionally used in appetite stimulation the resulting increase in food intake ultimately triggers anabolism. Animal model studies have revealed that the furostanol saponin fraction is responsible for the anabolic effects of fenugreek seeds.

In addition, the furostanol class of plant steroids have pronounced immunostimulating and luteinizing hormone (LH) releasing properties. LH in turn signals the pituitary gland to produce more testosterone and high testosterone levels have been correlated with improved athletic performance. The mechanism of hormone releasing action of furostanols is linked to the conversion of cholesterol into active hormones, resulting in the simultaneous reduction of plasma cholesterol levels.

Please call Sabinsa Corporation for further information and samples.

 
   
 

Kavita Subramanian : Marketing Executive

 
 
 

Kavita joined Sabinsa Corporation last year and has quickly become the heart and soul of the Customer Service and Marketing Department.

Kavita received her Masters degree in Politics from the University of Delhi, India and subsequently worked as Guest Relations Officer in an international hotel wherein she gathered extensive customer service experience and the flair for international communication.


At Sabinsa, Kavita interacts with a wide range of customers. She assists customers in finding the specific products they require, helps to schedule their shipments and informs the customers of any new and upcoming products. She enjoys working with people and believes that a smile goes a long way with customers.

At home, Kavita likes to unwind by practicing her classical dancing. Kavita has also been a professional classical dancer, with stage performances in India, France and Japan.

 
   
  Check out the Sabinsa Website!  
 
 
Sabinsa is now accessible on the internet. Our website can be contacted at www.sabinsa.com and has information on products and staff, as well as back issues of the Sabinsa Newsletter. We also have a visitor Guest Book, so please leave your name and any comments you may have. We are always interested in your feedback!
 
   
  Sabins's Globaltrek with Ayurveda  
 
 
On December 20th 1997, Dr. Muhammed Majeed (President of Sabinsa) was privileged to be invited to give a presentation on "Innovative Phytochemicals and Fine Chemicals" at the 49th Indian Pharmaceutical Congress held in Trivandrum, India. The Souvenir Magazine prepared for this meeting featured an article entitled "Ayurveda and Indo-Tibetan Materia Medica: Alternative Medicine Goes Mainstream for Better Health Care Delivery" written jointly by Dr. Majeed and Dr. Vladimir Badmaev. Copies of this article are available at this website at http://www.sabinsa.com/products/ayurveda_paper.htm and printed copies may be obtained by contacting Sabinsa.

This month, Dr. Badmaev heads to Russia to reintroduce the Badmaev line of products to his native country. We wish him a safe and productive visit!

 
     
 
"The information presented in the "Current Issues" Newsletter from Sabinsa Corporation is for informational purposes only. It is abstracted from web and print media sources. Readers are advised to refer to the original sources for additional information".
 
   
Copyright © 2007 Sabinsa Corporation All Rights Reserved